Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
H Takahash. Acute dystonia induced by adding midodrine, a selective alpha 1 agonist, to risperidone in a patient with catatonic schizophrenia. The Journal of neuropsychiatry and clinical neurosciences. vol 12. issue 2. 2000-09-15. PMID:11001613. |
acute dystonia induced by adding midodrine, a selective alpha 1 agonist, to risperidone in a patient with catatonic schizophrenia. |
2000-09-15 |
2023-08-12 |
Not clear |
F Angelucci, A A Mathé, L Alo. Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration. Journal of neuroscience research. vol 60. issue 6. 2000-09-06. PMID:10861791. |
the antipsychotics haloperidol and risperidone are widely used in the therapy of schizophrenia. |
2000-09-06 |
2023-08-12 |
rat |
R H Bouchard, C Mérette, E Pourcher, M F Demers, J Villeneuve, M H Roy-Gagnon, Y Gauthier, D Cliche, A Labelle, M J Filteau, M A Roy, M Maziad. Longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia. The Quebec Schizophrenia Study Group. Journal of clinical psychopharmacology. vol 20. issue 3. 2000-09-01. PMID:10831015. |
longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia. |
2000-09-01 |
2023-08-12 |
human |
R H Bouchard, C Mérette, E Pourcher, M F Demers, J Villeneuve, M H Roy-Gagnon, Y Gauthier, D Cliche, A Labelle, M J Filteau, M A Roy, M Maziad. Longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia. The Quebec Schizophrenia Study Group. Journal of clinical psychopharmacology. vol 20. issue 3. 2000-09-01. PMID:10831015. |
this study compared the long-term (12 months) effectiveness of risperidone (rp) with that of conventional neuroleptics (cns) in a population with chronic schizophrenia who had shown suboptimal response to cns. |
2000-09-01 |
2023-08-12 |
human |
S Frangou, M Lewi. Atypical antipsychotics in ordinary clinical practice: a pharmaco-epidemiologic survey in a south London service. European psychiatry : the journal of the Association of European Psychiatrists. vol 15. issue 3. 2000-08-24. PMID:10881220. |
the aim of this paper was to examine the use of atypical antipsychotics in clinical care, by means of a survey of prescribing practices for clozapine, risperidone, olanzapine, sertindole and quetiapine for all patients treated for dsm-iv schizophrenia within a psychiatric service. |
2000-08-24 |
2023-08-12 |
Not clear |
Z A Sharif, A Raza, S S Ratakond. Comparative efficacy of risperidone and clozapine in the treatment of patients with refractory schizophrenia or schizoaffective disorder: a retrospective analysis. The Journal of clinical psychiatry. vol 61. issue 7. 2000-08-21. PMID:10937608. |
comparative efficacy of risperidone and clozapine in the treatment of patients with refractory schizophrenia or schizoaffective disorder: a retrospective analysis. |
2000-08-21 |
2023-08-12 |
Not clear |
V P Kontaxakis, B J Havaki-Kontaxaki, S S Stamouli, G N Christodoulo. Optimal risperidone dose in drug-naive, first-episode schizophrenia. The American journal of psychiatry. vol 157. issue 7. 2000-07-19. PMID:10873934. |
optimal risperidone dose in drug-naive, first-episode schizophrenia. |
2000-07-19 |
2023-08-12 |
Not clear |
S Almond, O O'Donnel. Cost analysis of the treatment of schizophrenia in the UK. A simulation model comparing olanzapine, risperidone and haloperidol. PharmacoEconomics. vol 17. issue 4. 2000-07-19. PMID:10947493. |
to compare the costs of 2 atypical drug therapies (olanzapine and risperidone) with one another and with a conventional antipsychotic (haloperidol) in the treatment of schizophrenia. |
2000-07-19 |
2023-08-12 |
Not clear |
S Raskin, G Katz, Z Zislin, H Y Knobler, R Durs. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation. Acta psychiatrica Scandinavica. vol 101. issue 4. 2000-07-14. PMID:10782556. |
clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation. |
2000-07-14 |
2023-08-12 |
Not clear |
S Raskin, G Katz, Z Zislin, H Y Knobler, R Durs. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation. Acta psychiatrica Scandinavica. vol 101. issue 4. 2000-07-14. PMID:10782556. |
clozapine and risperidone were the first two antipsychotic drugs of a new class of agents for the pharmacotherapy of schizophrenia. |
2000-07-14 |
2023-08-12 |
Not clear |
E Kennedy, F Song, R Hunter, A Clarke, S Gilbod. Risperidone versus typical antipsychotic medication for schizophrenia. The Cochrane database of systematic reviews. issue 2. 2000-07-06. PMID:10796543. |
risperidone versus typical antipsychotic medication for schizophrenia. |
2000-07-06 |
2023-08-12 |
Not clear |
L de Haan, J Lavalaye, D Linszen, P M Dingemans, J Booi. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. The American journal of psychiatry. vol 157. issue 6. 2000-06-29. PMID:10831489. |
subjective experience and striatal dopamine d(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. |
2000-06-29 |
2023-08-12 |
Not clear |
L de Haan, J Lavalaye, D Linszen, P M Dingemans, J Booi. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. The American journal of psychiatry. vol 157. issue 6. 2000-06-29. PMID:10831489. |
the authors' goal was to study the relationship between subjective experience during treatment with olanzapine or risperidone and dopamine d(2) receptor occupancy in stabilized patients with schizophrenia. |
2000-06-29 |
2023-08-12 |
Not clear |
S Hiros. Effectiveness of risperidone in simple schizophrenia: a single case report. The Journal of clinical psychiatry. vol 61. issue 4. 2000-06-02. PMID:10830153. |
effectiveness of risperidone in simple schizophrenia: a single case report. |
2000-06-02 |
2023-08-12 |
Not clear |
H Y Lane, W C Chiu, J C Chou, S T Wu, M H Su, W H Chan. Risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels. The Journal of clinical psychiatry. vol 61. issue 3. 2000-05-25. PMID:10817107. |
risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels. |
2000-05-25 |
2023-08-12 |
Not clear |
H Y Lane, W C Chiu, J C Chou, S T Wu, M H Su, W H Chan. Risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels. The Journal of clinical psychiatry. vol 61. issue 3. 2000-05-25. PMID:10817107. |
the optimal risperidone dosing strategy for acute schizophrenia requires elucidation. |
2000-05-25 |
2023-08-12 |
Not clear |
H Y Lane, W C Chiu, J C Chou, S T Wu, M H Su, W H Chan. Risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels. The Journal of clinical psychiatry. vol 61. issue 3. 2000-05-25. PMID:10817107. |
we thus investigated whether dose reduction to diminish adverse reactions associated with ordinary risperidone doses could still yield efficacy for acutely exacerbated schizophrenia. |
2000-05-25 |
2023-08-12 |
Not clear |
S Madhusoodanan, M Brecher, R Brenner, J Kasckow, M Kunik, A E Negrón, N Pomar. Risperidone in the treatment of elderly patients with psychotic disorders. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. vol 7. issue 2. 2000-05-04. PMID:10322240. |
the authors evaluated the safety, tolerability, and efficacy of risperidone in 103 elderly patients (mean age, 71 years) with schizophrenia (75%) or schizoaffective disorder (25%). |
2000-05-04 |
2023-08-12 |
Not clear |
S Madhusoodanan, M Brecher, R Brenner, J Kasckow, M Kunik, A E Negrón, N Pomar. Risperidone in the treatment of elderly patients with psychotic disorders. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. vol 7. issue 2. 2000-05-04. PMID:10322240. |
risperidone was well tolerated and efficacious in elderly patients with schizophrenia or schizoaffective disorder. |
2000-05-04 |
2023-08-12 |
Not clear |
D H Nieman, L J Bour, D H Linszen, J Goede, J H Koelman, B P Gersons, B W Ongerboer de Visse. Neuropsychological and clinical correlates of antisaccade task performance in schizophrenia. Neurology. vol 54. issue 4. 2000-03-29. PMID:10690978. |
to elucidate pathophysiologic mechanisms involved in abnormal antisaccade task performance in schizophrenia by investigating a possible relationship among antisaccade task performance, neuropsychological test results, and symptomatology in a group of young patients with recent-onset schizophrenia; to compare the effects of olanzapine and risperidone on antisaccades and reflexive saccades. |
2000-03-29 |
2023-08-12 |
Not clear |